EMA — authorised 21 June 2022
- Marketing authorisation holder: AMRYT PHARMACEUTICALS DAC
- Status: approved
🇪🇺 Filsuvez in European Union
EMA authorised Filsuvez on 21 June 2022
Marketing authorisation
Filsuvez in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in European Union
Frequently asked questions
Is Filsuvez approved in European Union?
Yes. EMA authorised it on 21 June 2022.
Who is the marketing authorisation holder for Filsuvez in European Union?
AMRYT PHARMACEUTICALS DAC holds the EU marketing authorisation.